美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,350.48

+15.701.18%

涨家数：18

跌家数：2

平家数：- -

市盈率：- -

高：1,356.52

开：1,334.85

低：1,334.85

收：1,334.78

数据加载中...

美国疾病预防控制中心顾问将在拖延数月后审查疫苗指南

在美销售额占三成这家HMB供应商IPO提交注册

证券市场周刊

辉瑞(PFE.US)研发受挫引发收购猜测减肥药新贵股价大涨

辉瑞又双叒叕放弃一款口服 GLP-1，肥胖管线仅剩 1 款药物

Insight数据库

辉瑞4月14日成交额为13.66亿美元

辉瑞的GLP失败了

生物药大时代

强生4月14日成交额为16.43亿美元

吉利德科学4月14日成交额为6.73亿美元

阿斯利康4月14日成交额为4.03亿美元

美股抗疫概念股集体上涨，诺瓦瓦克斯医药涨超9%

每日经济新闻

吉利德科学盘中异动下午盘股价大涨3.01%报106.75美元

Co-Diagnostics, Inc.盘中异动股价大跌5.12%报0.350美元

美股三大股指走低，纳指转跌，辉瑞(PFE.N)一度回吐涨幅。

诺瓦瓦克斯医药盘中异动股价大涨5.03%

伊诺维奥制药盘中异动早盘股价大涨6.21%

Ocugen, Inc.盘中异动早盘股价大涨5.14%报0.726美元

Equillium, Inc.盘中异动早盘股价大涨5.85%

Biontech Se涨4.06% 股价突破100美元大关

英特尔(INTC)盘前升4.36% 将向SILVER LAKE出售ALTERA 51%的股份

辉瑞终止每日服用减肥药物研发后股价下跌

环球市场播报

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1350.4775,"timestamp":1745351999999,"preClose":1334.7778,"halted":0,"volume":89340824,"delay":0,"changeRate":0.011762,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":15.699707,"latestTime":"04-22 16:00:00 EDT","open":1334.8547,"high":1356.5189,"low":1334.8547,"amount":4208127625.527641,"amplitude":0.016231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.67431,"peRate":24.399045,"turnoverRate":0.005758,"increases":18,"decrements":2,"flats":0,"marketCap":1116116120071,"floatMarketCap":1096270001421.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1356.5189,"amplitude":0.016231,"preClose":1334.7778,"low":1334.8547,"pbRate":"3.67431","latestPrice":1350.4775,"volume":89340824,"delay":0,"open":1334.8547,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1332.2346,"twentyDayClose":1413.1478,"sixtyDayClose":1318.7274,"secType":"PLATE","market":"US","turnoverRate":0.005758,"peRate":24.399045,"marketCap":1116116120071,"floatMarketCap":1096270001421.5,"timestamp":1745351999999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":18,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527608184","title":"美国疾病预防控制中心顾问将在拖延数月后审查疫苗指南","url":"https://stock-news.laohu8.com/highlight/detail?id=2527608184","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527608184?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 18:00","pubTimestamp":1744711242,"startTime":"0","endTime":"0","summary":"美国疾病预防控制中心顾问将在拖延数月后审查疫苗指南会议因肯尼迪被任命为卫生部长而推迟 专家小组讨论 RSV 和基孔肯雅疫苗的指导方针正在审查 2025-2026 年接种 COVID 疫苗的建议Mariam Sunny/Sneha  S K. 路透4月15日 - 美国疾病控制和预防中心的外部专家小组在推迟近两个月后将于周二召开会议，预计将审查几种疫苗的指导方针，包括对下一代 COVID-19 疫苗的建议。肯尼迪否认 \"反疫苗\"，并表示他不会阻止美国人接种疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL4S3QT0U2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4547","NVAX","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2527462257","title":"在美销售额占三成 这家HMB供应商IPO提交注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2527462257","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527462257?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 16:25","pubTimestamp":1744705500,"startTime":"0","endTime":"0","summary":"全球最大的HMB供应商即将上市，核心产品市场份额稳定。4月3日， IPO企业技源集团股份有限公司通过了上市委会议，目前提交了注册。同期内，技源集团的氨糖产品销量分别为1874.41吨、2750.08吨和2590.54吨。据招股书披露，雅培集团是技源集团HMB业务的主要客户之一，报告期各期，技源集团向雅培集团的销售收入占主营业务收入的比例分别为 23.44%、17.38%和19.44%，占公司HMB业务收入的比例分别为69.26%、64.69%和66.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-15/doc-inetfxpw1048028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4082","LU2237957902.USD","BK4566","LU1023059063.AUD","LU1057294990.SGD","BK4533","LU1061106388.HKD","LU1989763690.USD","IE0002141913.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4581","BK4568","LU2089984988.USD","SG9999002224.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1691799644.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4504","SG9999004303.SGD","BK4588","LU1914381329.SGD","LU1721429741.USD","IE00BJJMRZ35.SGD","LU2237957811.SGD","LU2133065610.SGD","BK4592","SGXZ23171101.USD","LU1721429402.USD","LU1989763427.SGD","BK4585","LU0266013472.USD","ABT"],"gpt_icon":0},{"id":"2527745364","title":"辉瑞(PFE.US)研发受挫引发收购猜测 减肥药新贵股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2527745364","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527745364?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 15:04","pubTimestamp":1744700695,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞停止开发备受关注的口服减肥药Danuglipron，投资者押注这一挫折可能会刺激辉瑞寻求并购交易，几家开发减肥药的生物技术公司股价周一上涨。辉瑞此前表示，将停止开发备受关注的口服减肥药Danuglipron，因为一名参加临床试验的患者出现了潜在的药物性肝损伤。辉瑞一直试图与诺和诺德和礼来在减肥治疗市场竞争，但该公司在研发减肥药物方面已经落后于竞争对手。Danuglipron研发终止可能会使辉瑞的产品组合出现缺口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999002232.USD","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683264.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU0234572021.USD","LU1057294990.SGD","BK4534","PFE","IE00B19Z3581.USD","LU0058720904.USD","LU0456855351.SGD","SG9999002224.SGD","BK4599","LU0289739699.SGD","BK4007","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4588","BK4585","LU0306807586.USD","IE0002270589.USD","BK4533","BK4581","LU1883839398.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD","BK4550"],"gpt_icon":1},{"id":"2527341315","title":"辉瑞又双叒叕放弃一款口服 GLP-1，肥胖管线仅剩 1 款药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2527341315","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527341315?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 11:45","pubTimestamp":1744688751,"startTime":"0","endTime":"0","summary":"当地时间 4 月 14 日，辉瑞宣布终止开发口服胰高血糖素样肽-1受体激动剂 Danuglipron。安慰剂校正后，32 周时平均体重下降 8% 至 13%，26 周时平均体重下降 5% 至 9.5%。然而此次出现的潜在肝损伤病例，每日一次的Danuglipron 也终被辉瑞放弃。Danuglipron 并不是辉瑞在肥胖领域首次折戟的药物。在先后终止 Lotiglipron 和Danuglipron 开发后，目前辉瑞的肥胖药物管线仅剩一款口服 GIPR 拮抗剂PF-07976016，全球最高状态处于临床 II 期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415200413a459a994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415200413a459a994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","BK4590","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","BK4144","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","GLP","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2527010965","title":"辉瑞4月14日成交额为13.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527010965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527010965?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 10:09","pubTimestamp":1744682987,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，辉瑞成交额为13.66亿美元，成交额较昨日增加14.34%，当日成交量为6190.09万股。辉瑞于2025年4月14日涨0.96%，报22.12美元，该股过去5个交易日跌2.25%，年初至今跌15.24%，过去60日跌15.11%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|13.66亿|14.34%|6190.09万|#|2025-04-11|11.95亿|-24.16%|5507.81万|#|2025-04-10|15.75亿|-24.50%|7296.07万|#|2025-04-09|20.87亿|30.20%|9595.44万|#|2025-04-08|16.03亿|-17.07%|7240.60万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100950a6bab065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100950a6bab065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2527436727","title":"辉瑞的GLP失败了","url":"https://stock-news.laohu8.com/highlight/detail?id=2527436727","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527436727?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 09:44","pubTimestamp":1744681496,"startTime":"0","endTime":"0","summary":"4月14日，辉瑞宣布终止开发口服胰高血糖素样肽-1受体激动剂danuglipron，该药物此前正在研究用于慢性体重管理。在审查了所有信息，包括迄今为止为danuglipron生成的所有临床数据和监管机构的最新沟通后，辉瑞决定停止该分子的开发。市场对辉瑞制药撤回danuglipron的反应似乎有利于维京医疗、礼来和诺和诺德公司，因为慢性体重管理GLP-1受体激动剂领域的竞争可能会减少。因此，投资者对这些可能填补辉瑞制药退出这一药物类别留下空白的公司表现出更大兴趣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415131247a4594490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415131247a4594490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","LU0868494617.USD","BK4590","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","BK4144","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","LU0225771236.USD","PFE","SG9999001176.USD","GLP","LU0456855351.SGD","BK4550","SG9999001176.SGD","SGXZ57979304.SGD","LU1894683348.USD","LU1066051498.USD"],"gpt_icon":1},{"id":"2527317046","title":"强生4月14日成交额为16.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527317046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527317046?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 09:40","pubTimestamp":1744681235,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，强生成交额为16.43亿美元，成交额较昨日增加9.53%，当日成交量为1068.53万股。强生于2025年4月14日涨1.73%，报154.36美元，该股过去5个交易日涨2.48%，年初至今涨7.58%，过去60日涨5.29%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|16.43亿|9.53%|1068.53万|#|2025-04-11|15.00亿|-26.76%|994.39万|#|2025-04-10|20.48亿|-26.77%|1383.05万|#|2025-04-09|27.97亿|54.17%|1877.37万|#|2025-04-08|18.14亿|-33.02%|1201.84万|强生公司是世界上最大的、最多元化的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094036a6baaa89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415094036a6baaa89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1732799900.SGD","LU0114720955.EUR","LU2133065610.SGD","LU2089984988.USD","IE00B1BXHZ80.USD","LU2468319806.SGD","LU0058720904.USD","LU1894683264.USD","SG9999002224.SGD","LU1032466523.USD","SG9999002232.USD","JNJ","SG9999001440.SGD","LU1718418525.SGD","IE00BFTCPJ56.SGD","LU0098860793.USD","LU2129689605.HKD","LU1914381329.SGD","LU2430703178.SGD","BK4585","LU0912757837.SGD","LU0122379950.USD","LU0466842654.USD","LU0640476718.USD","LU1074936037.SGD","LU0203345920.USD","LU1778281490.HKD","BK4559","LU0234570918.USD","LU1244550221.USD","IE000M9KFDE8.USD","IE00B2B36J28.USD","BK4532","LU1032955483.USD","IE0034235303.USD","LU2602419157.SGD","LU0795875086.SGD","LU0889566641.SGD","LU1162221912.USD","LU1221951129.SGD","BK4568","BK4592","IE00BLSP4239.USD","IE00BN8TJ469.HKD","BK4007","IE0009355771.USD","LU0203347892.USD","LU0345770308.USD"],"gpt_icon":0},{"id":"2527170410","title":"吉利德科学4月14日成交额为6.73亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527170410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527170410?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 09:29","pubTimestamp":1744680598,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，吉利德科学成交额为6.73亿美元，成交额较昨日减少25.09%，当日成交量为633.53万股。吉利德科学于2025年4月14日涨2.77%，报106.5美元，该股过去5个交易日涨0.93%，年初至今涨16.11%，过去60日涨17.02%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093008a6baa73f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093008a6baa73f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1430594728.SGD","GILD","BK4550","IE0002270589.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","BK4578","LU0889565916.HKD","LU0109394709.USD","BK4568","BK4532","LU1839511570.USD","BK4566","BK4585","IE00B19Z3B42.SGD","LU2089984988.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU0289739699.SGD","LU2468319806.SGD","LU0234570918.USD","BK4588","IE00BSNM7G36.USD","BK4139","LU1585245621.USD","IE00B3T34201.USD","LU1066051498.USD","BK4583","IE00BKVL7J92.USD","LU1571399168.USD"],"gpt_icon":0},{"id":"2527617225","title":"阿斯利康4月14日成交额为4.03亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527617225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527617225?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 09:16","pubTimestamp":1744679789,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，阿斯利康成交额为4.03亿美元，成交额较昨日增加6.26%，当日成交量为593.99万股。阿斯利康于2025年4月14日涨2.59%，报68.01美元，该股过去5个交易日涨3.37%，年初至今涨5.25%，过去60日涨3.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|4.03亿|6.26%|593.99万|#|2025-04-11|3.79亿|-40.10%|576.15万|#|2025-04-10|6.33亿|-23.99%|976.31万|#|2025-04-09|8.32亿|-17.88%|1303.84万|#|2025-04-08|10.14亿|19.71%|1540.10万|1999 年，瑞典阿斯特拉公司与英国捷利康集团合并，成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091647a6baa380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091647a6baa380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU2462157665.USD","BK4568","AZN","LU2456880835.USD","LU2236285917.USD","BK4588","LU0320765992.SGD","LU2417539215.USD","BK4007","LU1829250122.USD","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2527123712","title":"美股抗疫概念股集体上涨，诺瓦瓦克斯医药涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527123712","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527123712?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 06:07","pubTimestamp":1744668455,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月15日，美股抗疫概念股集体上涨，Moderna涨超2%，吉利德科学涨逾2%，诺瓦瓦克斯医药涨超9%，BioNTech涨逾6%，阿斯利康涨超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504153376532774.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504153376532774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK4568","NVAX","BK4588","BK4547","BK4585"],"gpt_icon":0},{"id":"2527148609","title":"吉利德科学盘中异动 下午盘股价大涨3.01%报106.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527148609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527148609?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 02:41","pubTimestamp":1744656105,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日02时41分，吉利德科学股票出现异动，股价大幅拉升3.01%。截至发稿，该股报106.75美元/股，成交量350.056万股，换手率0.28%，振幅2.55%。吉利德科学股票所在的制药行业中，整体涨幅为2.30%。吉利德科学公司简介：吉利德科学开发和营销用于治疗威胁生命的传染病的疗法，其投资组合的核心集中在艾滋病毒，乙型和丙型肝炎。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150241459737b1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150241459737b1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","BK4583","LU2468319806.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","IE00B3T34201.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066051498.USD","LU1430594728.SGD","BK4532","BK4139","BK4568","LU0234570918.USD","LU2089984988.USD","IE0002270589.USD","GILD","BK4585","LU0109394709.USD","IE00B19Z3581.USD","BK4578","LU0289739699.SGD","LU1585245621.USD","BK4588","LU1839511570.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","BK4550","LU0320765992.SGD"],"gpt_icon":0},{"id":"2527115862","title":"Co-Diagnostics, Inc.盘中异动 股价大跌5.12%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527115862?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 00:52","pubTimestamp":1744649560,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日00时52分，Co-Diagnostics, Inc.股票出现异动，股价大幅跳水5.12%。截至发稿，该股报0.350美元/股，成交量5.5513万股，换手率0.17%，振幅7.91%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.25%。其相关个股中，Dih Holdings Us Inc C/Wts 20/04/2028 、Envoy Medical Inc C/Wts 29/09/2028 、Nanovibronix, Inc.涨幅较大，Nanovibronix, Inc.、Bluejay Diagnostics, Inc.、Venus Concept Inc.较为活跃，换手率分别为97.27%、30.53%、30.09%，振幅较大的相关个股有Dih Holdings Us Inc C/Wts 20/04/2028 、Ainos Inc C/Wts 29/07/2027 、Pavmed Inc C/Wts 30/04/2025 Class Z，振幅分别为91.67%、40.49%、32.50%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415005240a458b61d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415005240a458b61d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CODX","BK4568"],"gpt_icon":0},{"id":"2527119053","title":"美股三大股指走低，纳指转跌，辉瑞(PFE.N)一度回吐涨幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527119053","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527119053?lang=zh_cn&edition=fundamental","pubTime":"2025-04-15 00:15","pubTimestamp":1744647326,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BLSP4452.SGD","LU0122379950.USD","USJW.SI","BK4593","IE00BBT3K403.USD","SQQQ","BK4585","LU0234572021.USD","TQQQ","BK4592","03086","TSYW.SI","SG9999002232.USD","MNQmain","LU0170899867.USD","IE00B19Z3B42.SGD","LU1883839398.USD","NVIW.SI","BK4588","NQmain","PFE","QID","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0225771236.USD","BK4533","BK4568","QQQ","159659","QLD","IE0002270589.USD","USAW.SI",".IXIC","LU1057294990.SGD","BK4550","LU1894683264.USD","BK4534","SG9999002224.SGD","IE00BLSP4239.USD","PSQ","BK4561","LU1894683348.USD","LU0289739699.SGD","SG9999001176.USD","SGXZ57979304.SGD","SG9999003800.SGD","BK1147","BK4007","LU1066051498.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2527193073","title":"诺瓦瓦克斯医药盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527193073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527193073?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 22:35","pubTimestamp":1744641344,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时35分，诺瓦瓦克斯医药股票出现异动，股价大幅上涨5.03%。截至发稿，该股报6.16美元/股，成交量98.2805万股，换手率0.61%，振幅4.86%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为596.48%、314.04%、153.75%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Fate Therapeutics, Inc.，振幅分别为48.91%、29.90%、24.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414223544a4589ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414223544a4589ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4568","NVAX","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2527160074","title":"伊诺维奥制药盘中异动 早盘股价大涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527160074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527160074?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 22:13","pubTimestamp":1744640022,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时13分，伊诺维奥制药股票出现波动，股价急速拉升6.21%。截至发稿，该股报1.71美元/股，成交量12.6017万股，换手率0.34%，振幅3.42%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为1.35%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221342aa2c6e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221342aa2c6e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","BK4568","INO","BK4139"],"gpt_icon":0},{"id":"2527988331","title":"Ocugen, Inc.盘中异动 早盘股价大涨5.14%报0.726美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527988331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527988331?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 21:51","pubTimestamp":1744638678,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时51分，Ocugen, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报0.726美元/股，成交量61.2052万股，换手率0.21%，振幅3.27%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421511894d50f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421511894d50f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4568","OCGN"],"gpt_icon":0},{"id":"2527916797","title":"Equillium, Inc.盘中异动 早盘股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527916797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527916797?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 21:32","pubTimestamp":1744637541,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时32分，Equillium, Inc.股票出现异动，股价急速上涨5.85%。截至发稿，该股报0.507美元/股，成交量741股，换手率0.00%，振幅0.00%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为275.58%、131.78%、86.78%，振幅较大的相关个股有Verrica制药、Artelo Biosciences, Inc.、Silence Therapeutics Plc，振幅分别为17.60%、13.38%、10.98%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213221a4588eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213221a4588eea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2527646121","title":"Biontech Se涨4.06% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2527646121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527646121?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 21:31","pubTimestamp":1744637505,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分，Biontech Se股票出现波动，股价快速拉升4.06%。截至发稿，该股报100.44美元/股，成交量4.5374万股，换手率0.02%，振幅1.17%。Biontech Se股票所在的生物技术行业中，整体涨幅为0.67%。Biontech Se公司简介：BioNTech是一家总部位于德国的生物技术公司，专注于开发癌症治疗药物，包括个体化免疫疗法，以及包括冠状病毒在内的传染病疫苗。BioNTech与几家大型制药公司合作，包括罗氏、礼来、辉瑞、赛诺菲和Genmab。冠状病毒疫苗是其首个商业化产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421314697378377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421314697378377&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4535","BK4139","BNTX","BK4588","BK4585","BK4548","BK4551"],"gpt_icon":0},{"id":"2527165961","title":"英特尔(INTC)盘前升4.36% 将向SILVER LAKE出售ALTERA 51%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2527165961","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527165961?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 20:48","pubTimestamp":1744634924,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英特尔(INTC)盘前股价走高，暂升4.36%，报20.6美元。公司公布SILVER LAKE对ALTERA的投资，向SILVER LAKE出售ALTERA 51%的股份，英特尔将持有ALTERA业务剩余49%的股份。英特尔交易对ALTERA的估值为87.5亿美元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287487","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTC","BK4512","BK4535","BK4534","IE00B66KJ199.SGD","LU0321505439.SGD","BK4527","IE0031619046.USD","BK4579","BK4585","BK4550","LU0321505868.SGD","BK4602","IE00B19Z4B17.USD","LAKE","BK4202","BK4543","BK4529","BK4515","BK4141","BK4588","BK4533","BK4612","BK4568","BK4575","IE00B7SZL793.SGD","LU0081259029.USD","BK4605","BK4554"],"gpt_icon":0},{"id":"2527106152","title":"辉瑞终止每日服用减肥药物研发后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2527106152","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527106152?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 20:10","pubTimestamp":1744632600,"startTime":"0","endTime":"0","summary":"辉瑞表示将停止其每日服用减肥药物的研发后，其股价在盘前交易中下跌超过 1%。此前，在一项试验中，一名患者出现可能由该药物引起的肝损伤。\n　　辉瑞首席科学官克里斯・博肖夫博士在新闻稿中表示：“虽然我们对终止达努格列酮的研发感到失望，但我们仍致力于评估和推进有前景的项目，努力为患者带来创新的新药。”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-14/doc-inetcuqq9269022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0321505439.SGD","BK4534","IE0002270589.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0225771236.USD","LU1057294990.SGD","LU0868494617.USD","LU0058720904.USD","LU0225284248.USD","BK4585","LU1066051498.USD","SG9999003800.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","BK4599","IE00BLSP4239.USD","LU0306806265.USD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1894683348.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4568","LU1023059063.AUD","LU0170899867.USD","PFE","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","LU0321505868.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":175,"code":"91000000","status":"200"}]}}